Radiology Doctors in Waco, TX Accepting Medicare

25 Radiology doctors found. Showing 21 - 25

Dr. Gregory Joseph Bathurst, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3000 Herring Ave, Waco, TX 76708 Phone: 254-202-8525

Russell L Mcclellan, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3000 Herring Avenue, Waco, TX 76708 Phone: 254-202-2000    Fax: 254-753-6229

Howard N Klaskin, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 6901 Medical Pkwy, Radiology Department, Waco, TX 76712 Phone: 254-751-4000    Fax: 903-663-7394

Henry Julius Boehm, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3000 Herring Avenue, Waco, TX 76708 Phone: 254-202-2000    Fax: 254-753-6229

Thomas Brian White, MD Radiology - Vascular & Interventional Radiology Medicare: Accepting Medicare Assignments Practice Location: 3000 Herring Avenue, Waco, TX 76708 Phone: 254-202-2000    Fax: 254-753-6229

News Archive

Taylor & Francis publishes new microsite to provide full access to COVID-19 research

Taylor & Francis has published a new microsite that aggregates and organizes all recently published COVID-19 research in one easy to navigate portal, including all relevant research articles and book chapters.

NIH awards Sirnaomics SBIR grant for developing STP705 siRNA wound healing product

Sirnaomics, Inc. announced today that the company has been awarded another NIH SBIR grant for developing its small interfering RNA (siRNA) therapeutic product STP705 to improve skin wound healing with minimized scar formation.

Automated messages, telemonitoring effective in improving CPAP adherence among OSA patients

Patients with obstructive sleep apnea(OSA) are more likely to use CPAP, or continuous positive airway pressure, when their use is telemonitored and they receive individualized, automated messages that reinforce therapy adherence, according to a randomized, controlled trial published in the American Journal of Respiratory and Critical Care Medicine.

Trovagene to sell underwritten public offering of common stock

Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it is offering to sell shares of its common stock in an underwritten public offering. The offering is expected to price on or about Friday, February 6, 2015.

A new, potential treatment for nonalcoholic steatohepatitis with fibrosis

In the 2020 April 21 issue of Journal of Hepatology, a research group from the Department of Hepatology in Osaka City University Graduate School of Medicine, Japan reported that a new insight into the pathophysiology of human nonalcoholic steatohepatitis (NASH) with fibrosis and suggested a possibility of the new therapy using cytoglobin (CYGB) inducer for clinical application.

Read more Medical News

› Verified 1 days ago

• 1
• 2(current)